Long-Term TIE2 Inhibition in a TEK-Mutated Venous Malformation: A 3-Year Clinical Experience

Summary

This second long-term clinical experience supports the sustained efficacy and safety of TIE2 inhibition in selected <i>TEK</i>-mutated VMs and highlights the th...